knowledge -WSS

knowledge

author：knowledge 2025-08-23 18:37:27 - browse：8

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Pharma budget tightening trickles down to Doximity

WSS

Listen: Your guide to Wegovy's blockbuster heart study

Diversity in clinical trials starts with building trust, experts say

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Target recalls 2.2 million additional candles due to laceration, burn hazards

Newly revealed memo details efforts to keep Trump in power following election loss

explore

knowledge

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Cholera vaccine supply gets boost as demand surges globally

BioMarin wins approval for gene therapy to treat hemophilia A

Close Medicare's dangerous gaps in addiction treatment coverage

State Dept. review finds Biden bears some blame for Afghanistan failures

Cell therapy fails to slow type 1 diabetes, but safety is established

At least 13 dead in Texas as scorching temps continue

Diversity in clinical trials starts with building trust, experts say

Tori Bowie and the unacceptable rates of Black maternal death

Cholera vaccine supply gets boost as demand surges globally

explore

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

MultiPlan and major insurers sued for alleged medical price

H5N1 bird flu virus started spreading in cows in Texas in December

Pharma budget tightening trickles down to Doximity

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Close Medicare's dangerous gaps in addiction treatment coverage

hotspot

leisure time

hotspot

hotspot